Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

279 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages of Parkinson's disease: a cross-sectional PET study.
Liu SY, Wile DJ, Fu JF, Valerio J, Shahinfard E, McCormick S, Mabrouk R, Vafai N, McKenzie J, Neilson N, Perez-Soriano A, Arena JE, Cherkasova M, Chan P, Zhang J, Zabetian CP, Aasly JO, Wszolek ZK, McKeown MJ, Adam MJ, Ruth TJ, Schulzer M, Sossi V, Stoessl AJ. Liu SY, et al. Among authors: schulzer m. Lancet Neurol. 2018 Apr;17(4):309-316. doi: 10.1016/S1474-4422(18)30032-2. Epub 2018 Feb 16. Lancet Neurol. 2018. PMID: 29456161 Free PMC article.
Treatment for the progression of Parkinson's disease.
Calne D, Schulzer M, Mak E, Stoessl AJ. Calne D, et al. Among authors: schulzer m. Lancet Neurol. 2005 Apr;4(4):206. doi: 10.1016/S1474-4422(05)70026-0. Lancet Neurol. 2005. PMID: 15778097 No abstract available.
Visualizing vesicular dopamine dynamics in Parkinson's disease.
de la Fuente-Fernández R, Sossi V, McCormick S, Schulzer M, Ruth TJ, Stoessl AJ. de la Fuente-Fernández R, et al. Among authors: schulzer m. Synapse. 2009 Aug;63(8):713-6. doi: 10.1002/syn.20653. Synapse. 2009. PMID: 19391152
Dopamine turnover increases in asymptomatic LRRK2 mutations carriers.
Sossi V, de la Fuente-Fernández R, Nandhagopal R, Schulzer M, McKenzie J, Ruth TJ, Aasly JO, Farrer MJ, Wszolek ZK, Stoessl JA. Sossi V, et al. Among authors: schulzer m. Mov Disord. 2010 Dec 15;25(16):2717-23. doi: 10.1002/mds.23356. Mov Disord. 2010. PMID: 20939082
Age-specific progression of nigrostriatal dysfunction in Parkinson's disease.
de la Fuente-Fernández R, Schulzer M, Kuramoto L, Cragg J, Ramachandiran N, Au WL, Mak E, McKenzie J, McCormick S, Sossi V, Ruth TJ, Lee CS, Calne DB, Stoessl AJ. de la Fuente-Fernández R, et al. Among authors: schulzer m. Ann Neurol. 2011 May;69(5):803-10. doi: 10.1002/ana.22284. Epub 2011 Jan 18. Ann Neurol. 2011. PMID: 21246604
Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.
Wile DJ, Agarwal PA, Schulzer M, Mak E, Dinelle K, Shahinfard E, Vafai N, Hasegawa K, Zhang J, McKenzie J, Neilson N, Strongosky A, Uitti RJ, Guttman M, Zabetian CP, Ding YS, Adam M, Aasly J, Wszolek ZK, Farrer M, Sossi V, Stoessl AJ. Wile DJ, et al. Among authors: schulzer m. Lancet Neurol. 2017 May;16(5):351-359. doi: 10.1016/S1474-4422(17)30056-X. Epub 2017 Mar 20. Lancet Neurol. 2017. PMID: 28336296 Free PMC article.
279 results